Davidson David 4
4 · bluebird bio, Inc. · Filed Feb 18, 2021
Insider Transaction Report
Form 4
Davidson David
Chief Medical Officer
Transactions
- Award
Common Stock
2021-02-16+10,000→ 46,298 total - Award
Common Stock
2021-02-16+2,271→ 48,569 total - Sale
Common Stock
2021-02-17$28.16/sh−698$19,657→ 47,871 total - Award
Stock Option (right to buy)
2021-02-16+20,000→ 20,000 totalExercise: $28.44Exp: 2031-02-16→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2022, 25% on 01/04/2023, 25% on 01/04/2024, and 25% on 01/04/2025.
- [F2]Immediately vested restricted stock unit reflecting the equity portion of the reporting person's 2020 performance compensation.
- [F3]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F4]The range in prices for the transaction reported on this line was $27.97 to $28.54. The average weighted price was $28.1613. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]This stock option vests over a four-year period at the rate of 25% on 01/04/2022 and then in 36 equal monthly installments thereafter.